Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-30T15:27:56.807Z Has data issue: false hasContentIssue false
  • English
  • Français

Transcranial magnetic stimulation for the deficit syndrome of schizophrenia

Published online by Cambridge University Press:  24 June 2014

Perminder S. Sachdev
Perminder S. Sachdev*
Affiliation:
School of Psychiatry, University of New South Wales, Sydney, Australia Neuropsychiatric Institute, Euroa Centre, Prince of Wales Hospital, Sydney, Australia
*
Professor Perminder S. Sachdev, MD, PhD, FRANZCP, Neuropsychiatric Institute, Euroa Centre, Prince of Wales Hospital, Barker Street, Randwick, Sydney, NSW 2031, Australia. Tel: +61 2 9382 3763; Fax: +61 2 9382 3774; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
Acta Neuropsychiatrica , Volume 19 , Issue 1 , February 2007 , pp. 56 - 58
Copyright
Copyright © 2007 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kraepelin, E. Dementia praecox and paraphrenia. New York: Krieger 1971 (first published 1919).Google Scholar
Carpenter, WT Jr, Strauss, JS. The prediction of outcome in schizophrenia. IV: eleven year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991;179:517–525. CrossRefGoogle ScholarPubMed
Coffey, I. Options for the treatment of negative symptoms of schizophrenia. CNS Drugs 1994;1:107–118. CrossRefGoogle Scholar
Kane, J, Honigfeld, G, Singer, J, Meltzer, H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789–796. CrossRefGoogle ScholarPubMed
Siever, LJ, Davis, KL. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am J Psychiatry 2004;161:398–413. CrossRefGoogle ScholarPubMed
Berman, K. Functional neuroimaging in schizophrenia. In: Davis, KL, Charney, D, Coyle, JT, Nemeroff, C, eds. Neuropharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins, 2002: 745–755. Google Scholar
Selemo, LD, Goldman-Rakic, PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999;45:17–25. CrossRefGoogle Scholar
Olney, JW, Faber, NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995;52:998–1007. CrossRefGoogle Scholar
Tamminga, C. Glutamatergic aspects of schizophrenia. Br J Psychiatry 1999;37:S12–S15. Google Scholar
Swerdlow, NR, Koob, GF. Dopamine, schizophrenia, ania, depression: toward a unified hypothesis of cortico-striatal-pallido-thalamic function. Behav Brain Sci 1987;10:197–245. CrossRefGoogle Scholar
Lewis, DA, Hashimoto, T, Volk, DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005;6:312–324. CrossRefGoogle Scholar
Spencer, KM, Nestor, PG, Salisbury, DF, Shenton, ME, McCarley, RW. Abnormal neural synchrony in schizophrenia. J Neurosci 2003;23:7407–7411. Google Scholar
Volk, DW, Pierri, JN, Fritschy, J-M, Auh, S, Sampson, AR, Lewis, DA. Reciprocal alterations in pre- and post-synaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 2002;12:1063–1070. CrossRefGoogle Scholar
Freedman, R, Adler, LE, Myles-Worsley, Met al. Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. Arch Gen Psychiatry 1996;53:1114–1121. CrossRefGoogle ScholarPubMed
Daskalakis, ZJ, Christensen, BK, Chen, R, Fitzgerald, PB, Zipursky, RB, Kapur, S. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry 2002;59:347–354. CrossRefGoogle ScholarPubMed
Prikryl, R, Skotakova, S, Kasparek, T, Ceskova, E, Kucerova, H, Ustohal, L. Influencing negative symptoms of schizophrenia with repetitive transcranial magnetic stimulation (rTMS): a case study. Acta Neuropsychiatrica 2007;19:53–55. CrossRefGoogle ScholarPubMed
Chen, R, Classen, J, Gerloff, Cet al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997;48:1398–1403. CrossRefGoogle ScholarPubMed
Wu, T, Sommer, M, Tergau, F, Paulus, W. Lasting influence of repetitive transcranial magnetic stimulation on intracortical excitability in human subjects. Neurosci Lett 2000;287:37–40. CrossRefGoogle ScholarPubMed
Pascual-Leone, A, Tormos, JM, Keenan, J, Tarazona, F, Canete, C, Catala, MD. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J Clin Neurophysiol 1998;15:333–343. CrossRefGoogle ScholarPubMed
Loo, C, Mitchell, P, Sachdev, P, McDarmont, B, Parker, G, Gandevia, S. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry 1999;156:946–948. CrossRefGoogle ScholarPubMed
Cohen, E, Bernardo, M, Masana, Jet al. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. J Neurol Neurosurg Psychiatr 1999;67:129–130. CrossRefGoogle ScholarPubMed
Sachdev, P, Loo, C, Mitchell, P, Malhi, G. Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation. Psychiatry Clin Neurosci 2005;59:354–357. CrossRefGoogle ScholarPubMed
Nahas, Z, McConnell, K, Collins, Set al. Could left prefrontal rTMS modify negative symptoms and attention in schizophrenia? Biol Psychiatry 1999;45:S37S. Google Scholar
Klein, E, Kolsky, Y, Puyerovsky, M, Koren, D, Chistyakov, A, Feinsod, M. Right prefrontal slow repetitive transcranial magnetic stimulation in schizophrenia: a double-blind sham-controlled pilot study. Biol Psychiatry 1999;46:1451–1454. CrossRefGoogle ScholarPubMed
Langguth, B, Eichhammer, P, Kharraz, A, Wiegand, R, Hajak, G. Repetitive transkranielle magnetstimulation bei schizophrenie. Nervenheilkunde 2003;22:1764–1768. Google Scholar